Even the real, pharmaceutical-grade retatrutide causes significant side effects: nausea in 43% of people, diarrhea in 33%, and unusual skin sensations (tingling, burning) in about 1 in 5 people at the highest dose
Who qualifies for Ozempic
All the conditions the weight loss jab can tackle from addiction to Alzheimers Ozempic, a GLP-1 drug initially approved for diabetes, is being explored for various conditions beyond weight loss, including obesity-related diseases, colorectal cancer, osteoarthritis, substance abuse, brain disorders, skin conditions, sleep apnea, and polycystic ovary syndrome
Stanton EW, Manasyan A, Banerjee R, Hong K, Koesters E, Daar DA
A healthcare professional will start the dose of retatrutide at a lower level with the aim of allowing your body time to adjust